4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001567619-21-005397
Options or other derivatives
- General Counsel acquired 125,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROWLAND LLOYD A General Counsel | 2021-02-26 | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | D: show line 1 in the form |
Loading xslF345X03/doc1.xml…